Back to Authors

Wetzel, Jeanette

Mayo Clinic

Carisma Therapeutics (United States)

Citations 1

659 A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2 overexpressing solid tumors
Maziarz, Richard T, Yuan, Yuan , Krishnamurthy, Anuradha , Isaacs, James , Cairo, Mitchell S. , Cao, Felicia , Advani, Pooja , Locke, Kenneth W., WETZEL, J. M., Klichinsky, Michael , Condamine, Thomas , Sohal, Davendra , Abdou, Yara George , Pohlmann, Paula R. , Maziarz, Richard Thomas , Murthy, Hemant S. , Reiss, Kim A. , He, Aiwu Ruth , Blumenthal, Daniel J. , Locke, Kenneth, Wetzel, Jeanette, Kennedy, Eugene Paul

Regular and Young Investigator Award Abstracts | November 5, 2024 | Volume: No volume available | Issue: No issue available | Pages: A756-A756

10.1136/jitc-2024-sitc2024.0659 Get It